Media Center

The International Hospital Federation (IHF), a global organisation dedicated to advancing and promoting excellence in healthcare delivery and management worldwide, announced that it has elected Emirati Dr. Muna Tahlak, Chief Medical Officer of Dubai Academic Health Corporation (DAHC), Vice Provost Clinical Practice of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), and CEO of Latifa Hospital for Women and Children, as President of the Federation during the World Hospital Congress in Lisbon.

Dr. Tahlak's election as President of IHF is a major milestone for the UAE on the global healthcare front. As the first Arab woman and Emirati to hold this esteemed position, it underscores the UAE's commitment to both advancing the role of women across diverse fields and promoting excellence in the healthcare sector. This achievement also marks a remarkable moment in the history of the IHF, with Dr. Tahlak assuming the highest international position ever held within the organisation.

The IHF Governing Council voted to elect Dr. Tahlak as the new IHF President. In doing so, Dr. Tahlak ends her term as President Designate and now begins her two-year term as President of the IHF, succeeding Deborah J. Bowen, FACHE, CAE, President, and Chief Executive Officer of the American College of Healthcare Executives.

Dr. Tahlak expressed her gratitude and honour on being appointed, stating: “I extend my heartfelt appreciation to our visionary leadership for their unwavering commitment to empowering women. Emirati women have consistently excelled in diverse high-ranking roles across various domains. Our nation has also consistently offered abundant opportunities to foster the progress and specialisation of Emirati women, particularly within the medical field.

“This victory highlights not only the progress that Emirati women have made but also reflects the leading position of UAE’s health sector. I am honoured to represent the UAE and fellow Emirati women on such an important global platform,” she added.

Dr. Tahlak also noted that her work with the IHF over the past seven years has provided her with a platform to showcase the exemplary work of hospitals in the UAE and the invaluable contributions of Emirati women on a global scale.

Dr. Amer Sharif, CEO of Dubai Academic Health Corporation, congratulated Dr. Tahlak on her well-deserved appointment as the President of the International Hospital Federation, emphasising her exceptional leadership, expertise, and remarkable contributions to the healthcare system in Dubai and beyond. He also expressed his pride in Dr. Tahlak’s accomplishments and the recognition she brings to the exceptional talent of Emirati women on the global stage.

“This is an incredibly proud moment for the entire healthcare sector in the UAE. Emirati women have consistently excelled across various domains, particularly in the medical field, making substantial contributions to the nation's growth and development. Dr. Tahlak's leadership and dedication play a crucial role in fulfilling DAHC's mission to impact lives and shape the future of health through the integration of care, learning, discovery, and giving,” he said.

Dubai Academic Health Corporation (DAHC), Dubai’s first integrated academic health system, announced that it has earned the prestigious Gold Seal of Approval® by the Joint Commission International (JCI) across all its hospitals and primary care centers.

By maintaining its international accreditation, DAHC demonstrates a steadfast dedication to upholding healthcare excellence for patients and their families. The accreditation also reflects its commitment to becoming a global leader in providing exceptional patient care by maintaining the highest quality and safety standards.

The Joint Commission International, a leading accreditation body for hospitals and healthcare organizations worldwide, conducted a thorough evaluation process to award DAHC hospitals with the Gold Seal of Approval®. This evaluation concentrated on critical operational systems related to safety and encompassed various facets of patient care. JCI's comprehensive assessment examined the hospitals' adherence to rigorous global standards, with a particular emphasis on patient safety, clinical quality, and risk management protocols.

Dr. Muna Tahlak, Chief Medical Officer of DAHC and CEO of Latifa Hospital, said: “Receiving JCI accreditation across Dubai Academic Health Corporation hospitals and healthcare facilities is a tremendous accomplishment that speaks volumes about our unwavering commitment to delivering exceptional patient care. This recognition validates the hard work and dedication of our teams and demonstrates our ongoing pursuit of excellence in healthcare in line with our ‘Patient First’ promise.”

Joel Roos, Vice President, International Accreditation, Quality Improvement and Safety, Joint Commission International, said: “The accreditation offered by JCI equips hospitals with processes that foster improvements across multiple areas, such as staff education advancements and the implementation of leading practices within the hospital environment. We commend Dubai Academic Health Corporation for its dedication to becoming a quality improvement organization and reaching this prestigious milestone, which showcases a strong commitment to patient safety and quality.

By successfully securing JCI's accreditation, patients and their families can have even greater confidence in the care they receive at DAHC hospitals, affirming the organization's pledge to place its patients first.

In line with the UAE National Sports Strategy 2031 ..Dubai Academic Health Corporation and Dubai Sports Council sign MoU to boost the sports sector's support for humanitarian and charitable causes

Al Jalila Foundation, a global healthcare philanthropic organization dedicated to transforming lives through medical innovation, has signed a Memorandum of Understanding (MoU) with the Dubai Sports Council (DSC) aimed at enhancing the contributions of the sports sector towards humanitarian programs and charitable initiatives.

The signing of the agreement aligns with the UAE National Sports Strategy 2031 which was recently launched by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, to promote community well-being through sports. The Strategy seeks to foster a culture of physical activity, improve the capabilities of sports professionals, identify promising athletes in educational institutions, and modernize sports education methods and regulations.

During the ceremony, the ‘Champions of Hope’ tribute wall, dedicated to recognizing extraordinary sports personalities who have made significant contributions to Al Jalila Foundation, was inaugurated.

The inauguration of the tribute wall and the MoU signing ceremony was attended by His Excellency Saeed Hareb, Secretary General of DSC; Nasser Aman Al Rahma, Assistant Secretary General of DSC; Dr. Amer Sharif, Chief Executive Officer of Dubai Academic Health Corporation (DAHC); Dr. Amer Al Zarooni, Chief Executive Officer of Al Jalila Foundation, and representatives of DSC and DAHC.

Al Jalila Foundation has been officially designated as the charity partner of the Dubai Sports Council, marking a significant collaboration between the two entities. Together, they will embark on a series of initiatives aimed at promoting sports philanthropy and fostering a culture of sports, physical activity and inclusive participation across all segments of society.

Dr Amer Al Zarooni, CEO of the Al Jalila Foundation, said “Philanthropy possesses an extraordinary capacity to create lasting change. United by the common language of sport, the collaboration between Al Jalila Foundation and the DSC symbolizes DAHC’s unwavering dedication to elevate the overall health and well-being of people in the UAE.”

He added: “Sports provide an incredible platform to reach hundreds of thousands of individuals, promoting healthy lifestyles and generating funds for charitable endeavors. We take immense pride in the support we receive from numerous sporting legends, and it is truly inspiring to witness globally recognized athletes utilizing their influence to bring about positive change in people's lives. The Champions of Hope tribute wall will stand as a lasting testament to compassion, generosity and empowerment, leaving a legacy for future generations."

His Excellency Saeed Hareb, Secretary General of DSC, expressed his delight in signing the agreement with Al Jalila Foundation and conveyed his deep admiration for the remarkable societal and humanitarian accomplishments made thus far. “The role of sports has proven to be instrumental in supporting philanthropic initiatives and advancing medical research, ultimately making significant contributions to patient recovery. Sports stars play crucial roles, not only in terms of achieving outstanding results and bringing happiness to their fans, but also in actively supporting community, sports and humanitarian initiatives. Their involvement highlights the tireless efforts of national institutions, with Al Jalila Foundation being at the forefront, in making a positive impact on society.”

His Excellency added: “We have witnessed successful collaborations between DSC and Al Jalila Foundation in the past, always uniting our shared objectives of national sports, humanitarian endeavours and community service to benefit humanity.”

Champions of Hope Tribute Wall

Symbolic of the remarkable strength of community within the realm of sports, the Champions of Hope tribute wall serves as a showcase for sports memorabilia, including two Guinness World Records that were achieved through items sold at the Al Jalila Foundation charity auction in 2015. Notably, among these record-breaking items is a race helmet worn by HH Sheikh Mohammed bin Rashid Al Maktoum during his triumphant victory at the FEI World Endurance Championship in 2012, which fetched an astounding AED24 million. Additionally, the display features the exceptional AED2.4 million Al Yamamah saddle generously donated by His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, which he rode to victory at the 2014 Altech FEI World Equestrian Games held in Normandy, France.

Since its establishment, Al Jalila Foundation has been harnessing the power of sports to support its healthcare philanthropic programmes. Over the years, the Foundation has been part of iconic sporting events to help raise awareness around a number of causes. Through its engagement in these iconic sporting occasions, the Foundation has generated substantial funds to support its various programs including 7 Emirates Run, Beat Diabetes Walk, Pink is Punk.

Overall, Al Jalila Foundation has held a total of 300 sporting events and raised almost AED10 million. The latest partnership with DSC will further contribute to realizing the Foundation’s objective to transform lives through sports.

As the official Sports Ambassador for Al Jalila Foundation, the esteemed former Real Madrid footballer Michel Salgado has made significant contributions by donating his customized boots to the Foundation and fostering fruitful collaborations with renowned footballer and former Real Madrid goalkeeper, Iker Casillas, as well as esteemed corporate fundraising partners. In close partnership with Clarence Seedorf, a four-time UEFA Champions League winner, the Foundation strives to amplify awareness regarding the importance of cultivating a healthy lifestyle, especially among the younger generation.

Notably, MMA coach Javier Mendez, alongside an impressive line-up of top-tier fighters including the current UFC Lightweight Champion Islam Makhachev, UAE Warriors fighter Emirati Hadi Al Husseini, and the UAE's pioneering Emirati female boxer Fahima Falaknaz, have generously contributed signed items and are actively engaged in multiple initiatives in collaboration with the Foundation.

Dubai Academic Health Corporation’s vision is to advance health for humanity through the integration of care, learning, discovery and giving. Al Jalila Foundation advances DAHC’s giving mission to impact lives and shape the future of health through philanthropy.

For more information about Al Jalila Foundation please visit: www.aljalilafoundation.ae

The Dubai Academic Health Corporation (DAHC), AXDEV Global, and Pfizer Global announced a public-private partnership to enhance care for patients diagnosed with chronic illnesses, supported by an independent grant from Pfizer Global Medical Grants.

The goal of the collaboration is to establish an evidence-based model in performance and quality improvement to support the adoption of best practices and boost capacity development for patient care with chronic illnesses at the individual, team, practice, and health systems levels.

Dubai will serve as a test-bed to plan and implement the model, identified as the ideal city for the research given its diverse cultural population and unwavering support of its academic health system from the Dubai Academic Health Corporation.

The findings will then be scaled to enhance chronic illness care in low- and middle-income countries (LMICs) in Asia-Pacific, the Middle East, and North Africa.

The Dubai Academic Health Corporation will host the initiative at its medical university, Mohammed bin Rashid University of Medicine and Health Sciences (MBRU), and AXDEV will provide expert implementation research and project management across every step of the program.

All activities are supported by Pfizer’s independent grant including the research, development, and execution of medical education activities, toolkits and implementation science across multiple health centers in Dubai.

Through a research project out of MBRU, the research will take diabetes as a case example to apply and measure the impact of the interventions in four local health centers in Dubai. Today, diabetes is a chronic illness that affects almost one in every five adults in the UAE and is one of the leading causes of kidney failure globally.

The evidence and results gathered in Dubai will then be scaled to LMICs to reorganize chronic illness care and provide critical tools and education for clinicians, allied health professionals, staff and healthcare administrators.

Commenting on the importance of public-private partnerships, Dr. Hanan Alsuwaidi, Chief Business Officer of the Dubai Academic Health Corporation, said, “The healthcare industry has experienced significant changes since the pandemic. World-class healthcare systems are now turning to proficient partnerships to reimagine business models and access new capabilities. Public-private partnerships, like this one between the Dubai Academic Health Corporation, AXDEV and Pfizer, leverage the strength of all its members to accelerate the adoption of best practices in patient care.”

Suzanne Murray, Founder and CEO of AXDEV Group, stated, “This public-private collaboration, that will bring cutting edge education solutions for healthcare professionals and their teams to directly impact clinical practice, is a testimony that three major organizations, as well as the health centers involved, are committed to improving patient health outcomes with evidencebased and quality education and implementation research.”

Yasser El Dershaby, Vice President, MERA Regional Cluster Medical Lead, Pfizer, also commented on the importance of health equity. “Accessible healthcare for patients living with chronic illnesses is critical given that they are tethered to the healthcare system. Especially in LMICs, it has always been Pfizer’s goal to enhance health equity in underserved communities. Our new public-private partnership with The Dubai Academic Health Corporation and AXDEV Global brings us one step closer to bridging these gaps, and I look forward to the results from our initial research in Dubai.”

New fellowship programs in Pediatric Nephrology and Vascular Neurology 

DUBAI, United Arab Emirates, 15 JAN 2025: Dubai Health announced the opening of registration for its graduate medical education programs, including internship, residency, and fellowship training, at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU). For the first time, fellowship programs in Pediatric Nephrology and Vascular Neurology will be offered, aiming to develop highly skilled specialists and enhance healthcare education.

Professor Sulaiman AlEmran, Dean of Graduate Medical Education at MBRU, commented: “At Dubai Health, we are committed to delivering exceptional programs that enhance the expertise and capabilities of healthcare professionals. These initiatives reflect our dedication to preparing the next generation of leaders who will contribute to the advancement of the healthcare sector, and the addition of new programs reinforces our focus on delivering world-class medical education aligned with the highest international standards.”

Currently, MBRU offers 39 graduate medical education programs, including 20 residencies, 17 fellowships, and two internships. All are accredited by the Saudi Commission for Health Specialties (SCFHS), the National Institute for Health Specialties (NIHS) in the UAE, and the Arab Board of Health Specializations.

Dr. Rasha Buhumaid, Vice Dean of Graduate Medical Education at MBRU, commented: “The new fellowship programs in Pediatric Nephrology and Vascular Neurology are valuable additions to our programs offerings, reflecting Dubai Health’s commitment to an integrated educational and research environment. With plans to offer over 100 training seats annually in graduate medical education programs across various specialties, these programs align with our ‘Patient First’ promise, drive innovation in healthcare education while strengthening Dubai’s position as a global center for healthcare excellence.”

Applications for all programs are now open, as of 14 January. Interested candidates both from within the UAE and abroad can register online at www.mbru.ac.ae/graduate-medical-education.
The application deadline for residency programs is March 27, while internship and fellowship programs remain open until May 15.